• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » St. Jude takes over Medtronic’s CRM deal with hospital GPO

St. Jude takes over Medtronic’s CRM deal with hospital GPO

July 22, 2011 By MassDevice staff

Novation

The latest group purchasing organization deal for Upper Midwest Consolidated Services Center thumbs a nose at Medtronic’s (NYSE:MDT) controversial decision to cut several GPO deals earlier this year by replacing a Medtronic contract with a St. Jude Medical (NYSE:STJ) deal.

Irving, Texas-based UMCSC announced a one-year contract for cardiac rhythm management products with St. Jude this week, complementing an existing agreement with Boston Scientific Corp. (NYSE:BSX) and replacing an agreement with Medtronic.

"The 33 members of the Upper Midwest Consolidated Services Center (UMCSC) spend more than $110 million annually on CRM devices including pacemakers, implantable cardioverter defibrillators, heart failure devices, leads and related accessories," according to the press release.

UMCSC relies on fellow Lone Star State company Novation and the suppliers its collaborates with to shape its product portfolio, company officials said.

Medtronic made headlines — and pleased Wall Street — when it canceled several contracts for its cardiovascular and orthopedic products with Novation worth an estimated $2 billion a year. A few weeks later the Fridley, Minn.-based medical device giant spiked a deal with Premier Inc. for some of its spine products.

At the time, J.P. Morgan Chase & Co. analyst Michael Weinstein told the Wall Street Journal that spiking the Novation deal represented "a watershed moment" that could send ripples through the entire industry, positing that Medtronic would ditch other GPO deals as well.

But those ripples never materialized, as MDT rivals rushed to fill the vacancies left by the Fridley, Minn.-based firm.

Novation announced new partnerships of its own, adding electrosurgical and advanced cutting and coagulation products to its supply that it estimates will save $4.1 million for its members annually, according to a press release. Deals were struck with Covidien plc (NYSE:COV) , DeRoyal, Megadyne, Xodus, Buffalo Filter, Medline and Unimed, the company reported.

Filed Under: Business/Financial News, News Well Tagged With: Boston Scientific, Cardiac Rhythm Management, Deals Roundup, Novation, stjudemedical

More recent news

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • Ancora Heart reaches enrollment milestone in pivotal heart failure device trial
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Johnson & Johnson launches daily disposable multifocal toric contact lens
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy